纽约州 的 肺癌 临床试验
纽约州 有 93 项针对 肺癌 的研究正在招募参与者。
纽约州 的城市
- New York City60 项研究
- Queens22 项研究
- Greenburgh17 项研究
- Buffalo16 项研究
- Rochester15 项研究
- The Bronx13 项研究
- Staten Island12 项研究
- New Rochelle11 项研究
- Syracuse6 项研究
- Queensbury5 项研究
- Yonkers4 项研究
- Albany3 项研究
- Brooklyn3 项研究
- Rome3 项研究
官方研究文本（英文）
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- NYU Langone's Perlmutter Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- Optum Medical Care, PC, Westbury
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT06765109Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Northwell Health Imbert Cancer Center, Bay Shore
- Maimonides Medical Center, Brooklyn
- Roswell Park Cancer Institute, Buffalo
- 以及另外 18 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT04267848Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Glens Falls Hospital, Glens Falls
- Upstate Cancer Center at Oswego, Oswego
- University of Rochester, Rochester
- 以及另外 7 项
招募中3 期
70 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT06096844Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- The Cancer Institute at Saint Francis Hospital, East Hills
- 以及另外 13 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT04181060Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT06881784Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Montefiore Medical Center-Einstein Campus, The Bronx
- Montefiore Medical Center-Weiler Hospital, The Bronx
- Montefiore Medical Center - Moses Campus, The Bronx
- 以及另外 1 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT06498635A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- GSK Investigational Site, East Syracuse
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07099898Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- MSK Commack, Commack
- MSK Westchester, East White Plains
- Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
- 以及另外 3 项
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07476287Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- New York Oncology Hematology, Albany
- New York Oncology Hematology, Clifton Park
- Hematology Oncology Associates of Rockland, Nyack
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT07222566This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Hematology Oncology Associates of Rockland, Nyack
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06758401A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Cayuga Medical Center ( Site 0086), Ithaca
- University Hospital at Stony Brook ( Site 0054), Stony Brook
- White Plains Hospital ( Site 0091), White Plains
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06312137A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Roswell Park Cancer Institute IDS, Buffalo
- Memorial Sloan Kettering Hospital, New York
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06172478A Registry for People With Lung Cancer
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 以及另外 1 项
招募中观察性研究
18 岁及以上 · 所有性别 · 更新于 2026年9月24日 · NCT06424327Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, Buffalo
招募中2 期
18 至 95 岁 · 所有性别 · 更新于 2026年9月23日 · NCT05061550A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- WMCHealth Advanced Physician Services, Hawthorne
- Local Institution - 0128, Rochester
- Local Institution - 0518, Schenectady
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT07063745Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06128551Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
- NYU Langone Health, New York
- Weill Cornell Medical College, New York
- 以及另外 1 项
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07100080Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Nuvance Health, Poughkeepsie
- Suny-Stony Brook University Cancer Center, Stony Brook
- White Plains Hospital, White Plains
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06712316A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- NYU Langone Health Perlmutter Cancer Center, New York
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月21日 · NCT07629960Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Memorial Sloan Kettering Cancer Center, New York
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT06287775Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT07349537Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月16日 · NCT05786924The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
招募中1/2 期
12 岁及以上 · 所有性别 · 更新于 2026年9月15日 · NCT04585750Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月10日 · NCT06293898Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月9日 · NCT06625775A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- SUNY Upstate Medical University, Syracuse
- Montefiore Einstein Cancer Center, The Bronx
- Clinical Research Alliance, Westbury
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06793215A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Maimonides Cancer Center, Brooklyn
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
- 以及另外 3 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06119581A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06561685A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- NYU Langone Health - Long Island, Mineola
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月4日 · NCT06400472AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, New York
招募中1/2 期
18 至 75 岁 · 所有性别 · 更新于 2026年9月4日 · NCT07038343Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Roswell Park Cancer Institute, Buffalo
- Perlmutter Cancer Center - NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT06343402Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
招募中观察性研究欢迎健康志愿者
40 至 75 岁 · 所有性别 · 更新于 2026年9月2日 · NCT05334069Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月1日 · NCT07185997Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
- White Plains Hospital, White Plains
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月1日 · NCT06712355Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- New York Cancer & Blood Specialists, New York
- University of Rochester - Wilmot Cancer Institute, Rochester
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年8月27日 · NCT06582017Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung Cancer
- Roswell Park Cancer Institute, Buffalo
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年8月26日 · NCT07718672Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
- Roswell Park Cancer Institute, Buffalo
招募中
21 岁及以上 · 所有性别 · 更新于 2026年8月19日 · NCT05787834GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
- Roswell Park Cancer Institute, Buffalo
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年8月19日 · NCT07017829Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Northwell Health Imbert Cancer Center, Bay Shore
- Sands Cancer Center, Canandaigua
- Memorial Sloan Kettering Commack, Commack
- 以及另外 21 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月17日 · NCT05624996Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- NYU Langone Hospital - Brooklyn, Brooklyn
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- 以及另外 7 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月17日 · NCT06500481数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。